Family Medicine Doctors in Fruitport, MI Accepting Medicare
27 Family Medicine doctors found. Showing 1 - 20
 Chase Burton, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-8284 |
 Dr. Kristen Kay Woods, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 Fax: 231-672-2901 |
Nathan Dills, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Fizza Agha, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-727-5209 |
Lauren Mcgraw, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Kristina Powell, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Dominic Klosowski, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Dr. Faith Elizabeth Sharp, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Darrell S Roelandt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 Fax: 231-672-2901 |
Zahi Y Kanaan, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Ramey Soukup, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
David W Ziemke, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Kristen M Wagner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 Fax: 231-672-2901 |
Christopher David Anderson, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Mr. David Leon Dora, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 Fax: 231-672-2901 |
Sandra Raehtz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Lane Thomas Olds, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Anthony V Izokaitis, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 Fax: 231-672-2901 |
Amanda Mcgettigan, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
Samuel John Nystrom, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3443 Farr Rd, Fruitport, MI 49415 Phone: 231-672-2900 |
News Archive
UH launches careers of 5 NSF Graduate Research Fellows for 2011
The University of Houston (UH) launched the graduate careers of five National Science Foundation (NSF) Graduate Research Fellows for 2011. Recognizing outstanding students pursuing research-based master's and doctoral degrees in NSF-supported science, technology, engineering and mathematics disciplines, the three-year fellowships cover tuition and include a $30,000 annual stipend.
Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes
Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.
N30 Pharma begins oral dosing in N91115 Phase 1 trial for treatment of cystic fibrosis
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Maven Semantic updates gastroesophageal reflux research database
The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
Road salt sprinkled on streets makes lakes, rivers, and wells saltier
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
› Verified 7 days ago
- 1(current)
- 2